Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870

Journal of Experimental Medicine

Volumn 197, Issue 6, 2003, Pages 789-799

  Masignani, Vega ^a   Comanducci, Maurizio ^a   Giuliani, Marzia Monica ^a   Bambini, Stefania ^a   Adu Bobie, Jeannette ^a   Aricò, Beatrice ^a   Brunelli, Brunella ^a   Pieri, Alessandro ^a   Santini, Laura ^a   Savino, Silvana ^a   Serruto, Davide ^a   Litt, David ^b   Kroll, Simon ^b   Welsch, Jo Anne ^c   Granoff, Dan M ^c   Rappuoli, Rino ^a   Pizza, Mariagrazia ^a  

^a CHIRON VACCINES   (Italy)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Antigen; Gene variability; Neisseria; Vaccine

Indexed keywords

GENE PRODUCT; LIPOPROTEIN; PROTEIN GNA1870; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BACTERICIDAL ACTIVITY; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE MODEL; GENE SEQUENCE; GENETIC RECOMBINATION; GEOGRAPHIC DISTRIBUTION; INFANT DISEASE; INFECTION PREVENTION; MENINGOCOCCEMIA; NEISSERIA MENINGITIDIS; NONHUMAN; PASSIVE IMMUNIZATION; POPULATION DYNAMICS; PRIORITY JOURNAL; PRODUCT RECOVERY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEPSIS; SEROTYPE; STRAIN IDENTIFICATION; VACCINATION;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; BASE SEQUENCE; FEMALE; GENES, BACTERIAL; HUMANS; INFANT; LIPOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS; PHYLOGENY; PROTEIN ISOFORMS; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; VACCINATION;

EID: 0037451178     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021911     Document Type: Article

References (42)

1. Andersen, B.M. 1978. Mortality in meningococcal infections. Scand. J. Infect. Dis. 10:277-282.
2. Edwards, M.S., and C.J. Baker. 1981. Complications and sequelae of meningococcal infections in children. J. Pediatr. 99:540-545.
3. Bedford, H., J. de Louvois, S. Halket, C. Peckham, R. Hurley, and D. Harvey. 2001. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ. 323:1-5.
4. Branham, S.E. 1953. Serological relationships among meningococci. Bact. Rev. 17:175-188.
5. Vedros, N.A. 1987. Development of meningococcal serogroups. In Evolution of Meningococcal Disease. N.A. Vedros, editor. CRC Press, Inc., Boca Raton, FL. 33-37.
6. Frasch, C.E. 1989. Vaccines for prevention of meningococcal disease. Clin. Microbiol. Rev. 2:S134-S138.
7. Achtman, M. 1995. Global epidemiology of meningococcal disease. In Meningococcal Disease. K. Cartwight, editor. John Wiley and Sons, Chichester, England. 159-175.
8. Caugant, D.A. 1998. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS. 106:505-525.
9. Maiden, M.C., J.A. Bygraves, E. Feil, G. Morelli, J.E. Russell, K. Urwin, Q. Zhang, J. Zhou, K. Zurth, D.A. Caugant, et al. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. USA. 95:3140-3145.
10. Gotschlich, E.C., T.Y. Liu, and M.S. Artenstein. 1969a. Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides. J. Exp. Med. 129:1349-1365.
11. Gotschlich, E.C., I. Goldschneider, and M.S. Artenstein. 1969b. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J. Exp. Med. 129:1367-1384.
12. Lepow, M.L., J. Beeler, M. Randolph, J.S. Samuelson, and W.A. Hankins. 1986. Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children. J. Infect. Dis. 154:1033-1036.
13. Costantino, P., S. Viti, A. Podda, M.A. Velmont, L. Nencioni, and R. Rappuoli. 1992. Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C. Vaccine. 10:691-698.
14. Ramsay, M.E., N. Andrews, E.B. Kaczmarski, and E. Miller. 2001. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet. 357:195-196.
15. Peltola, H. 1998. Meningococcal vaccines. Current status and future possibilities. Drugs. 55:347-366.
16. Hayrinen, J., H. Jennings, H.V. Raff, G. Rougon, N. Hanai, R. Gerardy-Schahn, and J. Finne. 1995. Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides. J. Infect. Dis. 171:1481-1490.
17. Finne, J., D. Bitter-Suermann, C. Goridis, and U. Finne. 1987. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J. Immunol. 138:4402-4407.
18. Rosenstein, N.E., B.A. Perkins, D.S. Stephens, L. Lefkowitz, M.L. Cartter, R., Danila, P. Cieslak, K.A. Shutt, T. Popovic, A. Schuchat, et al. 1999. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J. Infect. Dis. 180:1894-1901.
19. Cartwright, K., N. Noah, and H. Peltola. 2001. Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000. Vaccine. 19:4347-4356.
20. Sierra, G.V., H.C. Campa, N.M. Varcacel, I.L., Garcia, P.L. Izquierdo, P.F. Sotolongo, G.V. Casanueva, C.O. Rico, C.K. Rodriguez, and M.H. Terry. 1991. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14:195-207.
21. Bjune, G., E.A. Hoiby, J.K. Gronnesby, O. Arnesen, J.H. Fredriksen, A. Halstensen, E. Holten, A.K. Lindbak, H. Nokleby, E. Rosenqvist, et al. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet. 338:1093-1096.
22. Tappero, J.W., R. Lagos, A.M. Ballesteros, B. Plikaytis, D. Williams, J. Dykes, L.L. Gheesling, G.M. Carlone, E.A. Hoiby, J. Holst, et al. 1999. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. J. Am. Med. Assoc. 281:1520-1527.
23. Perkins, B.A., K. Jonsdottir, H. Briem, E. Griffiths, B.D. Plikaytis, E.A. Hoiby, E. Rosenqvist, J. Holst, H. Nokleby, F. Sotolongo, et al. 1998. Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J. Infect. Dis. 177:683-691.
24. Jódar, L., I.M. Feavers, D. Salisbury, and D.M. Granoff. 2002. Development of vaccines against meningococcal disease. Lancet. 359:1499-1508.
25. Pizza, M., V. Scarlato, V. Masignani, M.M. Giuliani, B. Arico, M. Comanducci, G.T. Jennings, L. Baldi, E. Bartolini, B. Capecchi, et al. 2000. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science. 287:1816-1820.
26. Comanducci, M., S. Bambini, B. Brunelli, J. Adu-Bobie, B. Aricò, B. Capecchi, M.M. Giuliani, V. Masignani, L. Santini, S. Savino, et al. 2002. NadA, a novel vaccine candidate of Neisseria meningitides. J. Exp. Med. 195:1445-1454.
27. Harris, S.L., J.J. King, W. Ferris, and D.M. Granoff. 2003. Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysacchardie vaccine. Infect. Immun. 71:275-286.
28. Nakai, K., and M. Kanehisa. 1991. Expert system for predicting protein localization sites in Gram-negative bacteria. Proteins. 11:95-110.
29. de Lorenzo, V., S. Wee, M. Herrero, and J.B. Neilands. 1987. Operator sequences of the aerobactin operon of plasmid CoIV-K30 binding the ferric uptake regulation (fur) repressor. J. Bacteriol. 169:2624-2630.
30. Laemmli, U.K., M. Virji, H. Kayhty, D.J. Ferguson, C. Alexandrescu, and E.R. Moxon. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
31. Jennings, G.T., S. Savino, E. Marchetti, B. Aricó, T. Kast, L. Baldi, A. Ursinus, J. Holtje, R.A. Nicholas, R. Rappuoli, and G. Grandi. 2002. GNA33 from Neisseria meningitidis serogroup B encodes a membrane-bound lytic transglycosilase (MltA). Eur. J. Biochem. 269:3722-3731.
32. Schlegel, A., O. Danot, E. Richet, T. Ferenci, and W. Boos. 2002. The N terminus of the Escherichia coli transcription activator Ma1t is the domain of interaction with Ma1Y. J. Bacteriol. 184:3069-3077.
33. Granoff, D.M., A. Bartoloni, S. Ricci, E. Gallo, D. Rosa, N. Ravenscrost, V. Guamieri, R.C. Seid, A. Shan, W.R. Usinger, et al. 1998. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid. J. Immunol. 160:5028-5036.
34. Grifantini, R., E. Bartolini, A. Muzzi, M. Draghi, E. Fringimelica, J. Berger, G. Ratti, K. Petracca, G. Galli, M. Agnusdei, et al. 2002. Previously unrecognized vaccine candidates against serogroup B meningococcus identified by DNA microarrays. Nat. Biotechnol. 20:914-921.
35. Peeters, C.C., I.J. Claassen, M. Schuller, G.F. Kersten, E.M. van der Voort, and J.T. Poolman. 1999. Immunogenicity of various presentation forms of PorA outer membrane protein of Neisseria meningitidis in mice. Vaccine. 17:2702-2712.
36. Yamaguchi, K., F. Yu, and M. Inouye. 1988. A single amino acid determinant of the membrane localization of lipoproteins in E. coli. Cell. 53:423-432.
37. Tettelin, H., N.J. Saunders, J. Heidelberg, A.C. Jeffries, K.E. Nelson, J.A. Eisen, K.A. Ketchum, D.W. Hood, J.F. Peden, R.J. Dodson, et al. 2000. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science. 287:1809-1815.
38. Parkhill, J., M. Achtman, K.D. James, S.D. Bentley, C. Churcher, S.R. Klee, G. Morelli, D. Basham, D. Brown, T. Chillingworth, et al. 2000. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature. 404:502-506.
39. Strutzberg, K., L. von Olleschik, B. Franz, C. Pyne, M.A. Schmidt, and G.F. Gerlach. 1995. Mapping of functional regions on the transferrin-binding protein (TfbA) of Actinobacillus pleuropneumoniae. Infect. Immun. 63:3846-3850.
40. Granoff, D.M., G.R. Moe, M.M. Giuliani, J. Adu-Bobie, L. Santini, B. Brunelli, F. Piccinetti, P. Zuno-Mitchell, S.S. Lee, P. Neri, et al. 2001. A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis. J. Immunol. 167:6487-6496.
41. Turner, D.P., K.G. Wooldridge, and D.A. Ala'Aldeen. 2002. Autotransported serine protease A of Neisseria meningitidis: an immunogenic, surface-exposed outer membrane, and secreted protein. Infect. Immun. 70:4447-4461.
42. Voulhoux, J.R. and J. Tommassen. Transport of lipoproteins to the cell surface in Neisseria meningitidis. Thirteenth International Pathogenic Neisseria Conference. NIPH, Oslo, Norway. September 1-6 2002. p. 31.